Page 1 of 1

Unique Device for Early Prediction of the Pulmonary Edema

PostPosted: Tue Nov 08, 2011 11:23 am
by Administrator
Technology: Pulmonary Edema Monitor (PEM) is a world's first non-invasive medical device that changes fundamentally the Pulmonary Edema (PED) treatment concept. Instead of treatment aimed at the developed clinical stage of PED, our strategy is its prevention. PED is an excessive accumulation of liquid in the lungs, which represents a serious risk of death and causes considerable suffering of patients. The situation could be improved significantly if PED treatment starts at the early stage. It is possible only by monitoring patients at risk of PED continuously.
The availability of PEM will change this situation radically and predict PED without false negative or false positive cases and send signal telemetrically to the appropriate medical personnel. Treatment that started before the appearance of the PED clinical signs according to PEM's indication prevents its development.

Innovative Aspects and Main Advantages:
▼ The device ensures stable and accurate results of monitoring patients without PED in hospitals, outpatient clinics and home
▼ The device is suitable for prediction of PED before appearance of clinical signs, early enough for treatment and prevention of PED development
▼ The device allows controlling and monitoring the results of medical treatment
▼ Non-invasive
▼ Zero False Readings in early prediction of Pulmonary Edema
▼ Low cost

Pulmonary Edema Monitor received the Gold Medal and Diploma at IENA 2004, International Exhibition "Ideas-Invention"New Products, Nurnberg", Germany.
The Company is looking for investment for the final stage of the project. For contact click here.

Re: Unique Device for Early Prediction of the Pulmonary Edem

PostPosted: Fri Nov 11, 2011 12:54 pm
by Gadi
What is the statistics of mortality and the spread of the disease?

Re: Unique Device for Early Prediction of the Pulmonary Edem

PostPosted: Fri Nov 11, 2011 1:31 pm
by Administrator
About 1.5% of the population of developed countries suffers from Chronic Heart Failure (CHF). According to the World Health Organization there are approximately 70 million CHF patients worldwide, with 5.5 million in the US and 28 million in Europe. In the USA alone, 0.5 million new patients are added every year. About 20% of CHF patients develop deterioration of heart function (decompensation), resulting in several unplanned re-hospitalizations every year. In-hospital mortality of CHF patients is about 10%, mostly due to late arrival to hospital.

Re: Unique Device for Early Prediction of the Pulmonary Edem

PostPosted: Mon Nov 14, 2011 1:13 am
by Roy
What is the underlying principle of the device working?